Eli Lilly & Co ($LLY)

6 tracked superinvestors hold Eli Lilly & Co (LLY), worth $11.2B combined, led by PRIMECAP team. Smart money is trimming LLY as of the latest 13F filings.

Current price

$1216.95

Drug Manufacturers - GeneralNYSEUS

+51.1%

1Y

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The…

Market cap

$910.2B

P/E

34.25

Div yield

0.5%

Revenue YoY

44.7%

Analyst target

$1270

Snapshot for context. For deep analysis use a stock screener — this page is about who owns it.

Superinvestors holding

6

tracked 13F / N-PORT funds

Combined value

$11.2B

disclosed long exposure

Tier-1 conviction

0

concentrated holders

Net this quarter

-2

1 buying · 3 selling

Smart money is net reducing LLY: 3 funds trimmed versus 1 adding.

The smart-money take on LLY

Eli Lilly & Co (LLY) appears mainly in diversified and quant books here (6 funds, $11.2B combined) rather than in concentrated conviction portfolios — read the holders below with that in mind.

The highest-conviction holder is PRIMECAP team, who has committed 8.1% of their portfolio to it.

No tracked fund opened a new position this quarter; 1 added and 3 trimmed, a net reduction.

Superinvestors holding LLY

InvestorMove% of their portfolioPosition value
3
PRIMECAP team

Vanguard PRIMECAP

Held8.1%$5.0B
3
Will Danoff

Fidelity Contrafund

Trimmed2.1%$2.9B
3
Steve Wymer

Fidelity Growth Company

Added2.7%$2.0B
2
David Shaw

D.E. Shaw

Held0.7%$1.1B
2
Paul Tudor Jones

Tudor Investment

Trimmed0.3%$145M
3
Polen Capital

Polen Growth

Trimmed5.6%$119M

Tier badge = signal quality: 1 concentrated conviction · 2 quant/multi (context) · 3 retail & diversified. Only Tier 1 holdings feed the consensus signal.

Options activity on LLY

Disclosed put/call positions — directional bets, not share ownership. A put is typically bearish or a hedge.

Puts (bearish / hedge)

Calls (bullish)

Frequently asked

Which superinvestors own LLY?

6 tracked funds hold Eli Lilly & Co (LLY), the largest being PRIMECAP team (Vanguard PRIMECAP) at 8.1% of its 13F portfolio. 0 of them are concentrated Tier-1 conviction managers.

Is smart money buying or selling LLY?

In the most recent 13F quarter, 1 tracked fund added or opened LLY and 3 trimmed it.

How much LLY do tracked funds hold?

Combined disclosed long exposure to LLY across tracked superinvestors is $11.2B as of the Mar 2026 filings.

Stocks often held alongside LLY

Holdings aggregated from the latest SEC 13F & N-PORT filings via FMP · Mar 2026 quarter. Long equity positions only, reported with up to a 45-day delay — for activity between filings see real-time moves. Not financial advice.